Delivery Order SPE2DB20D2104-SPE2DB25FMVLN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Eletriptan HBr 40 mg tablets in unit dose packaging (6-count). This competitively awarded, non-set-aside contract carries a ceiling value of $4,173.59 and has a firm fixed price structure, with an ultimate completion date of August 11, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Eletriptan HBr 40 mg tablet unit dose packs (6s) with a ceiling value of $1,000.83. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and running through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,815.17 on August 27, 2025, for the supply of Eletriptan HBr 40 mg tablets in unit dose packages of six. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 28, 2025. Eletriptan is a triptan-class medication used to treat acute migraine headaches, representing part of the agency's pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $8,218.11 to AmerisourceBergen Drug Corp for the supply of Eletriptan HBR 40 mg tablets in unit dose packaging (6 tablets per package). This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed pricing under a delivery order contract type. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.88 to AmerisourceBergen Drug Corp for the supply of Eletriptan HBr 20 mg tablets in unit dose packages of six on September 2, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively under open procurement requirements. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, with an ultimate completion date of September 3, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Eletriptan HBr 40 mg tablets in unit dose packages of six, with a ceiling value of $1,390.26 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Eletriptan HBR 40 mg Tablet UD 6s. The contract, valued at $1,273.33, has a firm fixed price and an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This is a $1,093.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the medication eletriptan HBR 20 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as AmerisourceBergen). The contract is for the provision of Eletriptan Hydrobromide 40 mg tablets, a specialty pharmaceutical product, to support military treatment programs and facilities. The award has a ceiling value of $2,672.72 and a performance period through April 9, 2024. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,568,508,331 units of the medication eletriptan hydrobromide 40 mg tablets. The contract has a ceiling value of $1,242.28 and a period of performance through June 11, 2025. It is a firm-fixed price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVLNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eletriptan HBr 40 mg tablet unit dose packages (6-count), with a ceiling value of $1,119.38. This is a firm fixed price delivery order with no set-aside designation, issued competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order represents a routine pharmaceutical procurement under DLA's Medical Supply Chain operations, which supplies medications to military and veteran healthcare systems. Eletriptan is a migraine treatment medication commonly stocked within federal medical supply inventories. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a $999.9 billion prime indefinite delivery vehicle with DLA Troop Support Medical through December 2026, which enables the company to fulfill ongoing pharmaceutical supply needs across the global Defense Health Agency network and other federal healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies through competitive delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/14/25 |